Averin Capital appointed Akiko Moni Miyashita as a director, effective May 28, 2026.
IndividualAkiko Moni MiyashitaRoleMember of the Board (first class of directors)Type of ChangeAppointedEffective DateMay 28, 2026ReasonNot disclosedReplacement InfoNot disclosedBackground DetailsFounder of Beacon Hill Strategy Group (since Oct 2024); former Valo Health EVP & Chief Strategy Officer (May 2019–Sep 2024); prior roles at Halozyme board, McKinsey, Innosight, and IBM; 25+ years in strategy, finance, corp development (healthcare, life sciences, tech)Board/Committee Role ChangesNot disclosedOriginal SEC Filing:
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.